Fig. 1
Demographic and pathological information
| Characteristics | Variables | P-values |
|---|---|---|
| Age (year) | ||
| Mean | 54.62 | |
| Range (min-max) | 47-65 | |
| Gender | ||
| Male | 7 | |
| Female | 10 | |
| Procalcitonin (<0.1 ng/mL) | ||
| Mean | 18.43 | |
| Range (min-max) | 0.7-75.0 | 0.556 |
| Apache II Score (0-71) | ||
| Mean | 18.71 | |
| Range (min-max) | 10.0-28.0 | 0.980 |
| Bilirubin (0.2 – 1.2 mg/dL) | ||
| Mean | 1.43 | 0.516 |
| Range (min-max) | 0.6-2.3 | |
| Initial Platelet count (150-400 K/μL) | ||
| Mean | 31.71 | 0.980 |
| Range (min-max) | 20.0-47.0 | |
Day and patient wise effect of eltrombopag on platelet count
| Patient (n= 17) wise platelet count | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Day | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 |
| Day 1 | 24 | 30 | 21 | 37 | 26 | 34 | 39 | 30 | 47 | 20 | 24 |
| Day 2 | 39 | 41 | 32 | 53 | 30 | 69 | 69 | 45 | 65 | 23 | 36 |
| Day 3 | 68 | 70 | 58 | 51 | 65 | 96 | 121 | 61 | 76 | 35 | 69 |
| Day 4 | 84 | 86 | 89 | 76 | 86 | 121 | 133 | 130 | 51 | 91 | 92 |
| Day 5 | 102 | 109 | 116 | 92 | 129 | 144 | 169 | 127 | 98 | 112 | 106 |
| Day 6 | 119 | 127 | 123 | 136 | 151 | 152 | 186 | 142 | 103 | 139 | 133 |
| Day 7 | 136 | 162 | 147 | 142 | 155 | 178 | 216 | 159 | 142 | 158 | 164 |
| Day 8 | 154 | 186 | 165 | 155 | 162 | 155 | 244 | 166 | 165 | 162 | 161 |